Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/10/2012CA2816957A1 Compositions and methods for treating myelofibrosis
05/10/2012CA2816855A1 Combination therapy for prostate cancer using botanical compositions and bicalutamide
05/10/2012CA2816835A1 Formulations comprising polyethylene glycol
05/10/2012CA2816818A1 Skin wound healing compositions and methods of use thereof
05/10/2012CA2816797A1 Microsphere comprising a lanthanide metal complex
05/10/2012CA2816710A1 Compositions and methods for treating myelofibrosis
05/10/2012CA2816576A1 Bioerodible silicon-based devices for delivery of therapeutic agents
05/10/2012CA2816123A1 Compositions and methods for the delivery of therapeutics
05/10/2012CA2816121A1 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012CA2816027A1 Magnetic targeting device, system and method
05/10/2012CA2815959A1 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
05/10/2012CA2815792A1 Felbinac-containing external patch
05/10/2012CA2815280A1 A composition comprising s-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium
05/10/2012CA2814896A1 Sustained-release tablet and process for preparing the same
05/09/2012EP2450079A1 Needle-like material
05/09/2012EP2450047A1 Pharmaceutical composition containing ephedrae for treating bronchitis and preparation method therefor
05/09/2012EP2450046A1 A medicinal composition for the treatment of bronchitis and preparation thereof
05/09/2012EP2450045A1 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
05/09/2012EP2450043A1 Pharmaceutical composition for dermal use to treat psoriasis, sebopsoriasis or seborrhoic dermatitis comprising a vitamin D and a corticosteroid
05/09/2012EP2450041A2 Improved testosterone gel and method of use
05/09/2012EP2450038A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof
05/09/2012EP2450035A1 Combination of adapalene and benzoyl peroxide for treating acne lesions
05/09/2012EP2450034A1 Formulation based on the synthesis of microspheres made from cross-linked natural gelatine, used as a carrier for strains of probiotic lactobacillus spp. for treating skin wounds and/or lesions
05/09/2012EP2450033A1 Thermal shielding to optimize lyophilization process for pre-filled syringes or vials
05/09/2012EP2450032A2 Microvesicles derived from nucleated, mammalian cells and use thereof
05/09/2012EP2450031A1 Method for producing liposomes by two-stage emulsification method using outer aqueous phase containing specific dispersing agent, method for producing liposome dispersion or dry powder thereof using the method for producing liposomes, and liposome dispersion or dry powder thereof produced thereby
05/09/2012EP2449114A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors
05/09/2012EP2449106A1 Compositions and methods for silencing apolipoprotein b
05/09/2012EP2449044A1 Coating composition including marked polymers
05/09/2012EP2448919A2 Solubility and stability enchancing pharmaceutical formulation
05/09/2012EP2448907A2 Novel esters, and use thereof
05/09/2012EP2448610A2 In situ forming hydrogel and biomedical use thereof
05/09/2012EP2448589A1 Method for improving bioavailability of latanoprost
05/09/2012EP2448587A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
05/09/2012EP2448577A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders
05/09/2012EP2448576A2 Solubility enhancing pharmaceutical composition
05/09/2012EP2448575A2 Pharmaceutical composition increasing solubility and stability
05/09/2012EP2448571A1 Respirably dry powder comprising calcium lactate, sodium chloride and leucine
05/09/2012EP2448568A1 Improved formulation for nonsurgical exogenous crosslink therapy
05/09/2012EP2448567A1 Drug delivery system comprising polyoxazoline and a bioactive agent
05/09/2012EP2448566A2 Stable shellac enteric coating formulation for nutraceutical and pharmaceutical dosage forms
05/09/2012EP2448565A2 Transdermal composition comprising tolterodine
05/09/2012EP2448564A2 Solubility enhancing pharmaceutical formulation
05/09/2012EP2448563A2 3-cyanoquinoline tablet formulations and uses thereof
05/09/2012EP2448562A2 Raloxifene composition
05/09/2012EP2448561A1 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
05/09/2012EP2448560A1 Laboratory animal pulmonary dosing device
05/09/2012EP2448559A2 Liposomes for pulmonary application
05/09/2012EP2448558A1 Local therapeutic release device
05/09/2012EP2448557A1 Stimuli-responsive carriers for mpi-guided drug delivery
05/09/2012EP2448556A1 Antimicrobial material
05/09/2012EP2448555A1 Pharmaceutical ophthalmological liquid compositions containing propionic acid derivatives as a preservative
05/09/2012EP2448534A1 Apparatus and methods for implanting particulate ocular implants
05/09/2012EP2448413A1 Slow release magnesium composition and uses thereof
05/09/2012EP2448411A1 A method of treatment of a neurological disorder
05/09/2012EP2320870B1 Topical intranasal composition usable in the case of nasal obstruction
05/09/2012EP1679063B1 Novel liquid preparation composition
05/09/2012EP1585502B9 Fast-disintegrating solid dosage forms being not friable and comprising pullulan
05/09/2012EP1441589B1 Stable liquid pharmaceutical formulation of igg antibodies
05/09/2012EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy
05/09/2012EP1372610B1 Powder inhaler formulations
05/09/2012EP1323440B1 Peritoneal dialysates
05/09/2012CN202211874U Compound simvastatin niacin double-release capsule
05/09/2012CN1942173B Solid pharmaceutical preparation with improved stability and process for producing the same
05/09/2012CN1931294B Chinese medicine composition for treating ischemic apoplexy and its preparation process
05/09/2012CN1929838B Solid pharmaceutical preparation containing sparingly water-soluble drug
05/09/2012CN1861099B Snake oil soft capsule
05/09/2012CN1822844B Glycoside-containing liposome
05/09/2012CN1688339B Formulation of human antibodies for treating TNF-alpha associated disorders
05/09/2012CN1636577B Vaginal care composition
05/09/2012CN1596248B Phenoxy amine compounds and compositions for delivering active agents
05/09/2012CN102448488A Vaccine for mycoplasma infection
05/09/2012CN102448483A Peptide compositions for oral care systems
05/09/2012CN102448467A Methods for administration and formulations for the treatment of regional adipose tissue
05/09/2012CN102448460A Active pharmaceutical ingredient adsorbed on solid support
05/09/2012CN102448451A Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
05/09/2012CN102448449A Patch material
05/09/2012CN102448448A Controlled-release floating pharmaceutical compositions
05/09/2012CN102448447A Drug delivery composition
05/09/2012CN102448446A Coating agent for the dip coating of capsule halves
05/09/2012CN102448445A Orally disintegrating coated tablet
05/09/2012CN102448444A Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
05/09/2012CN102448443A Dry powder fibrin sealant
05/09/2012CN102448442A Treatment of tissue adhesion
05/09/2012CN102448440A Pharmaceutical formulations and methods for treating respiratory tract infections
05/09/2012CN102448439A Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
05/09/2012CN102448438A Anti-influenza formulations and methods
05/09/2012CN102448437A Compositions and methods for alleviating hyposalivation and for providing oral comfort
05/09/2012CN102448427A Composition
05/09/2012CN102441179A Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof
05/09/2012CN102441177A Nano bubble carrier for small interfering ribonucleic acid (siRNA) transfer
05/09/2012CN102441171A Local temperature-sensitive antibacterial drug sustained-release agent and preparation method thereof
05/09/2012CN102441169A Antibiotic compound containing beta-lactam antibiotics and ionic chelating agents
05/09/2012CN102441160A Thymosin alpha1 medicinal composition and preparation method thereof
05/09/2012CN102441158A Eye drop having Cecropins for pet and preparation method thereof
05/09/2012CN102441153A Recuperating oral liquid and manufacturing method thereof
05/09/2012CN102441152A Chinese medicinal liquor for treating rheumatic disease
05/09/2012CN102441150A Medicine composition for treating cardiac and pulmonary multi-viscera failure and preparation method thereof
05/09/2012CN102441149A Traditional Chinese medicine for treating alopecia, preparation method and quality control technology thereof
05/09/2012CN102441146A Purpose of white vein ointment in preparation of medicines for treating bone fractures
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 2991